Gimv Sells Major Stake in Rehaneo to Fremman Capital

Gimv, the European investment company, has announced the sale of its majority stake in Rehaneo to Fremman Capital. Rehaneo, established in 2020, is a key player in outpatient rehabilitation and other health services. The founders, CEO Bruno Crone and COO Christoph Dühr, retain significant investments and managerial roles. Since its inception during the COVID-19 pandemic, Rehaneo has become a leading outpatient rehab provider, integrating 13 companies at 23 locations in Germany, and employing over 1,000 staff to serve 80,000 patients annually.

Rehaneo's growth strategy focused on quality care and a successful buy-and-build model will continue with Fremman's backing. The deal, expected to conclude in Q1 2025 pending antitrust approval, promises a favorable impact on Gimv's earnings.